SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
232 hedge funds and large institutions have $432M invested in Sorrento Therapeutics, Inc. in 2021 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 70 increasing their positions, 58 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
34% less capital invested
Capital invested by funds: $656M → $432M (-$224M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
232
Holding in Top 10
1
Calls
$48.9M
Puts
$24.9M
Top Buyers
| 1 | +$10.7M | |
| 2 | +$4.22M | |
| 3 | +$3.6M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$2.97M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.29M |
Top Sellers
| 1 | -$3.05M | |
| 2 | -$2.44M | |
| 3 | -$2.35M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$2.16M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$1.59M |